fbpx
Colorado marijuana regulation bill overwhelmingly passes in House

Colorado marijuana regulation bill overwhelmingly passes in House

A Colorado marijuana regulation bill has been passed in the state house

It would restrict teens’ access to high-THC products and tighten rules for medical marijuana

The Colorado House of Representatives passed the state’s most substantial marijuana regulation policy since legalization on Thursday, intending to crack down on youth access to high-potency THC products and tighten rules for the medical marijuana market.

HB21-1317 passed overwhelmingly, 56-8, and moves on to the state Senate, where it is also expected to pass.

Some of the few House members who did criticize the bill argued data collection would lead to discrimination against consumers, as well as a slippery slope toward a fresh round of prohibitionist lawmaking.

Garnett disagreed, saying on the House floor just before the vote that he supports “making sure we all understand where this market has gone, how this (high-potency) market has expanded. … I just want to make sure that if there is an impact on the dev brain then we have public health research.

“We have waited too long to get to this point.”

Colorado’s legislative session must end no later than June 12, meaning this bill will move to the desk of Gov. Jared Polis in the next two weeks if it passes as expected.

Louisiana Marijuana Decriminalization Bill Advances To Senate

Louisiana Marijuana Decriminalization Bill Advances To Senate

Louisiana marijuana decriminalization bill has passed the house
A bill to decriminalize marijuana possession in Louisiana that already passed the House was approved in a Senate committee on Tuesday, sending it to the full chamber for final passage.
The legislation, sponsored by Rep. Cedric Glover (D), would make it so possession of up to 14 grams of cannabis would be punishable by a $100 fine without the threat of jail time. It cleared the Senate Judiciary C Committee in a 3-2 vote.

“House Bill 652 it seeks to address a problem that I think many of us have recognized over the years,” Glover said in opening remarks, adding that while opinions on full marijuana legalization vary, there’s widespread acceptance that low-level possession should not lead to incarceration or felony convictions.

If the decriminalization bill is approved on the Senate floor without amendments it will head to the governor’s desk.

This development comes as Louisiana lawmakers consider a number of separate marijuana bills this session, including one that would allow patients to access smokeable cannabis products. That measure has also passed the House and is pending action on the Senate floor.

A complementary bill to tax flower marijuana is also set to be taken up by the Senate.

The House additionally passed a resolution on Monday requesting the legislature conduct a formal study on the impacts of recreational marijuana legalization prior to the start of the 2022 session.

While advocates are encouraged by the modest reforms advancing, there is disappointment that a bill to enact adult-use legalization was pulled by its sponsor this month after the House defeated a companion bill to tax recreational sales.

Skittles Manufacturer Sues Cannabis Brands for Trademark Infringement

Skittles Manufacturer Sues Cannabis Brands for Trademark Infringement

Skittles is suing Zkittles cannabis brands

Skittles-maker Mars Wrigley has filed lawsuits against cannabis companies in Illinois, California, and Canada for trademark infringement.

New Jersey-based candy maker, Mars Wrigley, is suing cannabis companies in Illinois, California, and Canada to stop them from using its brand names and marketing for infused edibles, the Chicago Sun-Times reports. The lawsuit, filed in federal court, accuses the companies of infringing on the Starburst and Skittles candy brands, Ganjapreneur reports.

Mars Wrigley strongly condemns the use of popular candy brands in the marketing and sale of THC products, which is grossly deceptive and irresponsible. The use of Mars Wrigley’s brands in this manner is unauthorized, inappropriate and must cease, especially to protect children from mistakenly ingesting these unlawful THC products. – Mars Wrigley in a statement via the Sun-Times

The lawsuit names Terphogz and five companies that sell a cannabis strain and related products called Zkittlez, the report says. The unnamed defendants are “unknown” to  Mars Wrigley but they are accused of purchasing the goods in question to resell to Illinois customers.

The California lawsuit targets products called “Medicated Skittles,” “Life Savers Medicated Gummies,” and “Starburst Gummies” – marketed by GasBuds – which appear to mimic the packaging of the popular, non-cannabis, confections.

The legal actions are the latest against cannabis companies for trademark infringement of popular consumer products.

Atlanta, Georgia-based Edible Arrangements in September sued Chicago’s Green Thumb Industries for using their brand name in their Incredible product, according to the Sun-Times. Two months later, Ferrera Candy Co. sued California-based Tops Cannabis over its “Medicated Nerds Rope.”

Other lawsuits have brought over the “Woodstock” brand; the logo of a Massachusetts lumber company; the Citibank name, parodied as “Citidank;” the Tapatio hot sauce name and logo; the Gorilla Glue brand; and the logo of the National Hockey League’s Toronto Maple Leafs, among others.

Mars Wrigley is seeking $2 million for each counterfeit trademark named in the California lawsuit, along with attorneys’ fees and costs in both cases.

Why Delta-8 is Being Made Illegal

Why Delta-8 is Being Made Illegal

Delta-8 THC is illegal

As quickly as Delta-8 THC blew up, it’s being made illegal by states across the country.

It was only a matter of time.

Consumers and entrepreneurs have been an enjoying a regulation free, sub-legal way to get high and profit from Delta-8 THC. Now the DEA and USDA have taken notice, and in addition to the numerous states already taking action to make Delta-8 illegal on their own terms, the official law regarding Delta-8 is becoming more clear.

In fact, the current laws regarding hemp may already have it covered.

What is Delta-8 THC?

A very, very close relative to Delta-9 THC, the main psychoactive component of cannabis, Delta-8 THC is separated by just one subtle difference in its molecular structure. The similarity in molecular structure also leads to similar psychoactive effects although slightly suppressed.

Studies done on Delta-8 THC have revealed it to be roughly 75% the potency of traditional Delta-9 THC. With modern extraction technology and isolation techniques, manufacturers of D8 THC are able to produce products that get users high.

The reason that D8 THC is able to operate currently with near impunity is because of the wording of the 2018 Farm Bill. In the bill, “Hemp” is defined as:

The plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.

Because the definition specifically includes Delta-9 THC and nothing else, this has been used by manufacturers as a de facto legalization of other tetrahydrocannabinols. However, looking a little more deeply into current rules and regulations on the books by the DEA and USDA, and depending on your definition of “synthetic”, the future of Delta-8 may have already been decided.

Synthetic Tetrahydrocannabinols

In August of 2020, the DEA released a set of interim rules regarding hemp. In this ruling they say, “For tetrahydrocannabinols that are naturally occurring constituents of the plant material, Cannabis sativa L., any material that contains 0.3% or less of D9 -THC by dry weight is not controlled, unless specifically controlled elsewhere under the CSA,” CSA being the Controlled Substances Act.

However in the same paragraph further down, we get to the part that matters to Delta-8 THC advocates; “For synthetically derived tetrahydrocannabinols, the concentration of D9 -THC is not a determining factor in whether the material is a controlled substance. All synthetically derived tetrahydrocannabinols remain schedule I controlled substances.

By establishing a difference between naturally occurring cannabinoids that are produced in hemp and those that are derived and enhanced synthetically, the DEA virtually made a ruling against Delta 8. This is because, to the likely surprise of many (including myself), Delta 8 THC while naturally occurring in hemp, is in fact synthetically made from CBD when produced for retail sale.

How Delta 8 THC is Made

All cannabinoids, from CBD to THC and beyond begin as CBGA. Because of the shared molecular structure of cannabinoids, manipulating them is simpler than it may seem. While Delta-8 is relatively new, producers have been using these methods to manipulate cannabinoids for a long time to find exotic new cannabinoids.

While Delta-8 THC exists in a wide range of cannabis strains, it is in minuscule, trace amounts. To extract and purify Delta-8 from raw plant material with less than one percent of the targeted cannabinoid is unprofitable. This is why producers have begun converting other, more prevalent cannabinoids like CBD and Delta-9 THC into Delta-8.

The process of creating Delta 8 from CBD is nothing new, and is actually a patented isomerization process. It involves dissolving CBD in a solvent like heptane. An acid is then added into the solution and stirred constantly up to 18 hours on a heat plate. Once the chemical reaction is complete it will separate, where it can then be washed and dried and tested.

Compared to how your average Delta-9 extract is made, Delta-8 is a more lengthy, “synthetic” process. The Delta-8 is not there in the beginning, it is created in the end. And that’s why it’s a problem.

What does this mean for Delta 8 THC?

Unfortunately for producers and consumers alike, the great days of Delta-8 THC are likely coming to an end sooner rather than later. Over a dozen states have already banned Delta-8 THC, and more are considering passing their own laws against the cannabinoid. With the ruling by the DEA being brought into the open, it will be difficult for manufacturers to argue that Delta-8 is not in fact a synthetic cannabinoid.

In other words, those who continue to manufacture and sell Delta-8, even right now, are technically manufacturing and distributing a Schedule 1 substance. States in which Delta-8 THC has not been explicitly banned likely don’t need to worry about prosecution for the time being, as no official ruling on Delta-8 specifically has been passed down.

But as concern grows and more states ban Delta-8, it is going to become more difficult and less profitable for manufacturers to continue making it. Soon enough, Delta-8 will likely be another banned substance nationwide.

CULTA Launches Maryland’s First Cannabis Tissue Culture Program

CULTA Launches Maryland’s First Cannabis Tissue Culture Program

CULTA medical marijuana dispensary Baltimore, Maryland

Maryland medical cannabis cultivator CULTA has launched the state program’s first tissue culture lab in an effort to further hone its approach to craft cannabis and extracts. Chief Cannabis Officer and co-founder Mackie Barch said that it’s a natural next step in the company’s growth plans and cultivation goals.

The team took their first tissue culture clones on April 8. (The news comes just a few months after CULTA moved its headquarters to a new office in Bethesda to accommodate a long-term growth strategy, which includes plans to add 100 more employees across its farm in Cambridge, retail dispensary in Baltimore and new HQ.)

CULTA’s current collection of 26 cultured strains includes: Dosido 22-22, Poochie Love and Scooby Snacks #2. New mothers are expected in the coming months. The plan is to bank all of CULTA’s genetics in the lab by the end of the year.

The prime motivation was “to ensure redundancy of our genetics, the ability to create clean new moms and to be able to store genetics for long periods of time,” Barch said. “The long-term implications are to ensure we don’t lose prized genetics to disease and age. Additionally, we can store more genetics in a safer manner and bring them back as needed.”

Cannabis strains can be moved in and out of production without a lot of additional cost. This flexibility translates to a greater engagement with sales trends in Maryland.

Looking ahead, the lab will also allow CULTA to develop an in-house breeding program.

“Plant tissue culture is not a hard process to do, but it takes a lot of knowledge and skill to master,” CULTA Tissue Culture Lab Supervisor Isaac Fisher said. “Lab experience is extremely beneficial, especially if it involves microbiology, mycology, botany or biochemistry. No new employees we’re brought on specifically for the Tissue Culture lab. I have past experience working in a molecular genetics lab, but started out at CULTA doing outdoor cultivation and then working in the extraction lab before helping start the tissue culture lab.”

Texas Marijuana Concentrates and Psychedelics Bill Passed in Senate

Texas Marijuana Concentrates and Psychedelics Bill Passed in Senate

Texas marijuana concentrates and psychedelics got a big win in the state senate

The Texas Senate has approved House-passed bills to reduce criminal penalties for possessing marijuana concentrates and require the state to study the therapeutic potential of psychedelics like psilocybin and MDMA. But because senators amended both pieces of legislation, they must first head back to their originating chamber before they can be sent to the governor’s desk.

Meanwhile, advocates are closely monitoring a separate bill to expand the state’s medical cannabis program, which cleared the House and was referred to a Senate committee on Thursday. But the fate of that proposal remains murky as a legislative deadline approaches. It must be acted on in the Senate State Affairs Committee in order to advance to the floor, and the end of the session is nearing.

Under HB 1802, which passed the Senate on Saturday in a 25-5 vote, the state would be required to study the medical risks and benefits of psilocybin, MDMA and ketamine for military veterans in partnership with Baylor College of Medicine and a military-focused medical center. As amended by a House committee, it would also mandate a clinical trial into psilocybin for veterans with PTSD, in addition to a broader review of the scientific literature on all three substances.

The Senate adopted a balanced budget amendment to the bill clarifying that the psychedelic studies wouldn’t be carried out unless there’s funding allocated the effort—a situation already accounted for by a contingent rider for the funds.

Former Gov. Rick Perry (R), who also served as U.S. energy secretary, has called on lawmakers to approve the psychedelics legislation.

The cannabis concentrates measure that also advanced through the Senate is a modest reform compared to another proposal to more broadly decriminalize marijuana possession that recently passed the House but has since stalled. But if enacted, HB 2593 would mark the first time that Texas has reduced penalties associated with marijuana since the 1970s.

Social Share Buttons and Icons powered by Ultimatelysocial
error

Like The Real Dirt? Please spread the word :)